Vir Biotechnology

About:

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Website: http://www.vir.bio

Twitter/X: vir_biotech

Top Investors: ARCH Venture Partners, Bill & Melinda Gates Foundation, SoftBank Vision Fund, GlaxoSmithKline, Alta Partners

Description:

Vir Biotechnology is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases. The company brings together cutting-edge innovations with scientific expertise and management. It seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. Vir Biotechnology also focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company four current technology platforms are designed to, either individually or in combination, stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Their vision is that one day, diseases like hepatitis B, influenza A, HIV, and tuberculosis become a thing of the past.